Trial intelligence / Profile preview

Patient Satisfaction with Botox for Glabellar Lines

NCT00856414Phase 4Completed

Sponsor
Allergan
Start
Mar 2009
Primary completion
Apr 2009
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 4 trial of onabotulinumtoxinA in glabellar lines, sponsored by Allergan. Started Mar 2009; status: completed.

02

Drugs

onabotulinumtoxinA
03

Conditions

glabellar lines

Beyond the preview

Go deeper on NCT00856414.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00856414.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call